Disease modifying therapies and infection risks in multiple sclerosis-a decision-making conundrum

被引：6
|
作者：
Yong, Kok Pin [1 ,2 ,3 ]
Kim, Ho Jin [3 ]
机构：
[1] Natl Neurosci Inst, Dept Neurol, Singapore, Singapore
[2] Duke NUS Grad Med Sch, Singapore, Singapore
[3] Res Inst & Hosp Natl Canc Ctr, Dept Neurol, Goyang, South Korea
来源：
ANNALS OF TRANSLATIONAL MEDICINE | 2020年 / 8卷 / 11期
基金：
新加坡国家研究基金会;
关键词：
OCRELIZUMAB; LYMPHOPENIA; RITUXIMAB;
D O I：
10.21037/atm.2020.01.119
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页数：4
相关论文
共 50 条
  • [1] Disease-modifying therapies and infectious risks in multiple sclerosis
    Winkelmann, Alexander
    Loebermann, Micha
    Reisinger, Emil C.
    Hartung, Hans-Peter
    Zettl, Uwe K.
    NATURE REVIEWS NEUROLOGY, 2016, 12 (04) : 217 - 233
  • [2] Disease-modifying therapies and infectious risks in multiple sclerosis
    Alexander Winkelmann
    Micha Loebermann
    Emil C. Reisinger
    Hans-Peter Hartung
    Uwe K. Zettl
    Nature Reviews Neurology, 2016, 12 : 217 - 233
  • [3] A qualitative study assessing patient perspectives in the process of decision-making on disease modifying therapies (DMT's) in multiple sclerosis (MS)
    van Capelle, Archibald de Ceuninck
    van der Meide, Hanneke
    Vosman, Frans J. H.
    Visser, Leo. H.
    PLOS ONE, 2017, 12 (08):
  • [4] Disease modifying therapies in multiple sclerosis
    Sharrack, B.
    Jenkins, T.
    INTERNATIONAL JOURNAL OF CLINICAL PRACTICE, 2010, 64 (05) : 532 - 534
  • [5] Disease modifying therapies in multiple sclerosis
    Khatri, BO
    McQuillen, MP
    NEUROLOGY, 2002, 59 (03) : 471 - 472
  • [6] Infection risks in multiple sclerosis therapy by infusion of disease modifying drugs
    Winkelmann, A.
    Loebermann, M.
    Reisinger, E. C.
    Hartung, H-P.
    Zettl, U. K.
    NERVENARZT, 2015, 86 (08): : 971 - +
  • [7] Disease modifying therapies in multiple sclerosis - Reply
    Goodin, DS
    NEUROLOGY, 2002, 59 (03) : 472 - 473
  • [8] RANKING OF DISEASE -MODIFYING THERAPIES FOR MULTIPLE SCLEROSIS
    Fogarty, E.
    Schmitz, S.
    Walsh, C.
    Barry, M.
    VALUE IN HEALTH, 2015, 18 (07) : A750 - A750
  • [9] Disease modifying therapies for relapsing multiple sclerosis
    Wingerchuk, Dean M.
    Weinshenker, Brian G.
    BMJ-BRITISH MEDICAL JOURNAL, 2016, 354
  • [10] Multiple sclerosis and disease-modifying therapies
    Minen, Mia T.
    Karceski, Steven
    NEUROLOGY, 2011, 77 (04) : E26 - E26
12345